4//SEC Filing
OLUKOTUN ADEOYE Y 4
Accession 0001209191-23-016446
CIK 0000879407other
Filed
Mar 5, 7:00 PM ET
Accepted
Mar 6, 6:04 PM ET
Size
5.6 KB
Accession
0001209191-23-016446
Insider Transaction Report
Form 4
OLUKOTUN ADEOYE Y
Director
Transactions
- Sale
Common Stock
2023-03-03$32.65/sh−11,350$370,578→ 7,867 total
Footnotes (2)
- [F1]The price reported on Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.36 to $32.88, inclusive. The reporting person undertakes to provide to Arrowhead Pharmaceuticals, Inc., any security holder of Arrowhead Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4.
- [F2]Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person which are subject to certain vesting conditions.
Documents
Issuer
ARROWHEAD PHARMACEUTICALS, INC.
CIK 0000879407
Entity typeother
Related Parties
1- filerCIK 0001242615
Filing Metadata
- Form type
- 4
- Filed
- Mar 5, 7:00 PM ET
- Accepted
- Mar 6, 6:04 PM ET
- Size
- 5.6 KB